Christopher Patusky - Sep 3, 2024 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Stock symbol
UTHR
Transactions as of
Sep 3, 2024
Transactions value $
-$894,497
Form type
4
Date filed
9/5/2024, 04:30 PM
Previous filing
Jul 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $123K +700 +77.78% $175.43 1.6K Sep 3, 2024 Direct
transaction UTHR Common Stock Sale -$252K -700 -43.75% $360.31 900 Sep 3, 2024 Direct F1
transaction UTHR Common Stock Options Exercise $754K +4.3K +477.78% $175.43 5.2K Sep 4, 2024 Direct
transaction UTHR Common Stock Sale -$1.52M -4.3K -82.69% $353.36 900 Sep 4, 2024 Direct
holding UTHR Common Stock 1.1K Sep 3, 2024 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Options Options Exercise $0 -700 -4.67% $0.00 14.3K Sep 3, 2024 Common Stock 700 $175.43 Direct
transaction UTHR Stock Options Options Exercise $0 -4.3K -30.07% $0.00 10K Sep 4, 2024 Common Stock 4.3K $175.43 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $360.17 to $360.635. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.